06
2025
-
06
A Detailed Guide to the Prototype-Production Process for Foldable Paper Boxes—From a Paper “Blueprint” to Precise Manufacturing
Proofing is the process of verifying product color and manufacturing techniques based on the customer’s design drawings or provided physical samples prior to mass production, ultimately transforming the product’s 2D design into a tangible 3D prototype to showcase its real‑world appearance to the customer.
Author:
Design files: Includes vector graphics, renderings, die-cut line art, and sample boxes.
Textual materials: Drug name, ingredient information, dosage and administration instructions, and other explanatory text
Logo-related assets: Brand logo source files, registered trademark vector graphics, and certification mark files.
Size standards
Box type : Straight boxes, hook-bottom boxes, mortise-lock boxes, custom-shaped boxes, etc.
Internal dimensions : Based on the actual dimensions of the drug packaging bottle/box, plus a 2–5 mm buffer space.
External dimensions : Set the stacking modulus based on the dimensions of the transport container.
Material Selection : Confirm basis weight, thickness, and surface treatment
Cardboard-type : 200–400 g white cardboard (suitable for standard packaging boxes)
Specialty paper : Textured paper / Pearlized paper, etc. (grammage and grain direction must be specified)
Composite material : Gray board laminated with coated paper, etc. (specify the gray board thickness and the lamination process)
Basic Process : Matte / Glossy Lamination (please specify film thickness: 25μ/30μ)
Special process : Local UV (with spot‑color coverage indicated), hot foil stamping (with a specified metallic shade), C² laser transfer printing
Tactile craftsmanship : Embossing/Debossing (please provide a sample for confirmation of the pattern depth)
Spot Color Standard : Pantone color numbers must correspond to the annual color swatch (e.g., with TPX/TCX suffixes)
Four-color mode : CMYK values must be accompanied by a print color gamut simulation diagram.
Color Difference Control : Limited ΔE ≤ 1.0
Drug Name and Labeling
· The generic name must be distinctive (location/ Font/color highlighting is permitted; the product name must not exceed half the size of the generic name and cannot appear on the same line.
· Prohibit the use of decorative fonts and unauthorized trademarks or names.
Regulations on the Labeling of National Drug Approval Numbers
· The product must bear an approved registration number; verify that the registration number and product information match those approved by the National Medical Products Administration.
Drug supervision code assignment
· The pharmaceutical traceability code consists of 20 digits, with the first 7 digits serving as the drug identification code and the remaining 13 digits as the drug serial number.
Special Drug Labeling
· Anesthetic, psychotropic, toxic, and radioactive drugs must be marked with special labels (e.g., “Anesthetic,” “Toxic”).
Over-the-counter drug proprietary mark
· Class A OTC : Red background with white lettering (e.g., cold and fever medications).
· Class B OTC : White text on a green background (e.g., vitamin supplements).
Generic Drug One-Time Evaluation Mark
· Generic drugs that have passed the consistency evaluation may display the “Consistency Evaluation” logo prominently on the front of their packaging.
The CTP department uses specialized design and production software to generate die‑cutting layouts and conduct small‑batch proofing.
Key Points in Die-Tool Design
1. Outline the vector-based contour paths of the packaging flat pattern, including die-cut lines, crease‑fold lines, adhesive‑tab lines, and other structural reference lines.
2. Specify the core specification dimensions (e.g., box height, net length and width, and insert tab extension length), and indicate the material thickness tolerance compensation parameters.
3. Leave a 1.5 mm bleed margin around all sides to prevent white edges from showing after the trimming process.
4. Layout die-cut registration lines and printing overprint marks, employing a dual‑positioning mechanism to ensure precise alignment between the printed design and the die‑cutting process.
02
The production process is carried out sequentially, including inkjet coding, printing, surface treatment, hot stamping, embossing of Braille, die-cutting, quality inspection, and box gluing, to verify compliance with the specified manufacturing process.
Finally, submit the proof sample to the client for review, with particular attention to:
Content Accuracy : The printed content, including text and graphics, is consistent with the customer’s signed design draft.
Color Consistency: The color gradient of the standard sample and the upper- and lower-limit samples meets Customer requirements;
Process Integrity : The hot-stamping position, die-cutting accuracy, and box-gluing strength all meet the internal quality standards.
From design to mass production, our pharmaceutical packaging boxes are the result of seamless collaboration across multiple departments—R&D, manufacturing, quality assurance, and compliance—ensuring that customer‑specific requirements are met to the fullest extent. The sample‑approval card, serving as a cross‑departmental milestone, not only formalizes process parameters but also establishes the definitive execution standards for transitioning to full‑scale production.
Zhejiang Yuanjin Packaging Co., Ltd. consistently upholds the quality philosophy of “Good packaging for good medicines,” ensuring that every pharmaceutical package meets both regulatory requirements and functional standards through standardized processes, meticulous control, and end-to-end collaboration. Moving forward, we will continue to respond to customer needs with a rigorous work ethic, leverage technological innovation to enhance service experiences, and safeguard both the brand value of pharmaceutical companies and the medication safety of patients.
Sales Hotline: 0575-86198933
Address: No. 10, Damingshi Road, Yulin Subdistrict, Xinchang County, Shaoxing City, Zhejiang Province
Keywords:
Related Information
2026-11-07
2024-08-29